What is Acutis Diagnostics?
Acutis Diagnostics operates as a specialized clinical laboratory focused on PCR testing for a range of infectious diseases, including urinary tract infections, and toxicology lab testing. The company provides essential services to medical providers, biopharmaceutical partners, and patients, emphasizing rapid turnaround times and advanced diagnostic capabilities. By delivering actionable data and insights, Acutis Diagnostics aims to elevate patient care through the integration of innovative technology and dependable testing methodologies. Their commitment to maintaining high standards is reinforced by accreditations and a strong dedication to customer service.
How much funding has Acutis Diagnostics raised?
Acutis Diagnostics has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Acutis Diagnostics
PPP
Public-Private Partnership
What's next for Acutis Diagnostics?
The recent major strategic investment signals a period of accelerated growth and potential expansion for Acutis Diagnostics. This capital infusion is likely to fuel advancements in their PCR testing technology, broaden their service offerings, and potentially expand their market reach within the biopharma and healthcare provider sectors. The company's focus on actionable data and rapid turnaround times positions it to capitalize on the increasing demand for efficient and accurate diagnostic solutions, further solidifying its enterprise-level standing.
See full Acutis Diagnostics company page
